Does Nonapeptide-1 work?
Not properly: lab and cell work only, with no published human trial.
The published work on nonapeptide-1 is receptor and cell culture data showing it blocks the melanocyte-stimulating hormone receptor. There is no published controlled human trial of a nonapeptide-1 skin product in these sources. The cell-level mechanism is plausible; the brightening effect on real skin is undocumented. 13
These sources hold no peer-reviewed controlled trial of the peptide on human skin. A 2022 study is often cited in Advances in Dermatology and Allergology. It is a cell-culture study of the alpha-MSH to MC1R pathway. It is not a trial of the peptide in people. Claims of visible brightening rest on manufacturer testing that has not been published in full. 13
Evidence checklist
- Randomised controlled trial No human trial
- Human study over 100 people No human data
- More than one research group Manufacturer data sheet and cell work
- Clinical outcomes, not surrogate markers No clinical outcomes
- Human safety data beyond case reports No specific safety reports
Read the full Nonapeptide-1 page
More on Nonapeptide-1
Citations
- Chen 2022, Adv Dermatol Allergol: effects of tea polyphenols on UVA-induced melanogenesis via inhibition of the alpha-MSH to MC1R pathway doi.org
- FDA: how cosmetics are not FDA-approved but are FDA-regulated fda.gov
- MedChemExpress: nonapeptide-1 data sheet (supplier receptor and cell data) file.medchemexpress.com
Reference information only, not medical advice. Drawn from the Nonapeptide-1 article, fact-checked against the cited sources. No dosing anywhere on this site.